Low molecular weight heparin (reviparin) in percutaneous transluminal coronary angioplasty results of a randomized, double-blind, unfractionated heparin and placebo-controlled, multicenter trial (REDUCE trial)

✍ Scribed by Karl R. Karsch; Melitta B. Preisack; Rainer Baildon; Volker Eschenfelder; David Foley; Eulogio J. Garcia; Martin Kaltenbach; Christoph Meisner; Hans K. Selbmann; Patrick W. Serruys; Man F. Shiu; Martin Sujatta; Raoul Bonan

• Book ID: 118584514
• Publisher: Elsevier Science
• Year: 1996
• Tongue: English
• Weight: 877 KB
• Volume: 28
• Category: Article
• ISSN: 1558-3597
• DOI: 10.1016/s0735-1097(96)00343-9